AN4035 is a proprietary CEACAM5-targeting antibody drug conjugate (ADC) designed to deliver potent anti-tumor activity with an improved therapeutic window. It is armed with Adlai Nortye’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback